Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000454705 | SCV000540646 | likely benign | not specified | 2016-03-29 | criteria provided, single submitter | clinical testing | Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: No change to splice consensus |
Genome Diagnostics Laboratory, |
RCV000625144 | SCV000743871 | likely benign | Herpes simplex encephalitis, susceptibility to, 1 | 2017-06-02 | criteria provided, single submitter | clinical testing | |
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000625144 | SCV000745298 | likely benign | Herpes simplex encephalitis, susceptibility to, 1 | 2017-06-28 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV000625144 | SCV000768807 | benign | Herpes simplex encephalitis, susceptibility to, 1 | 2024-01-31 | criteria provided, single submitter | clinical testing | |
Genome |
RCV001824784 | SCV002074824 | not provided | not provided | no assertion provided | phenotyping only | Variant interpreted as Benign and reported on 04-27-2020 by Lab or GTR ID 500031. GenomeConnect assertions are reported exactly as they appear on the patient-provided report from the testing laboratory. GenomeConnect staff make no attempt to reinterpret the clinical significance of the variant. This variant was reported in an individual referred for clinical diagnostic genetic testing. |